Should governments choose to introduce
COVID19 testing for travelers arriving from countries considered
as high risk, IATA says that testing must deliver results fast, be
able to be conducted at scale, and operate to very high rates of
accuracy.
Additionally, testing must be cost-effective and
not create an economic or logistical barrier to travel.
“Airlines are committed to reducing the risks of
COVID19 transmission via air travel and COVID19 testing could play
an important role. But it must be implemented in line with ICAO’s
global re-start guidance with the aim of facilitating travel.
Speed, scale and accuracy are the most critical performance
criteria for testing to be effectively incorporated into the
travel process,” said Alexandre de Juniac, IATA’s Director General
and CEO.
Technology for rapid point-of-care Polymerized
Chain Reaction (PCR) testing could be a useful layer of protection
for travelers from countries considered as higher risk,
potentially removing the need for more burdensome and intrusive
measures such as quarantine which is a major barrier to travel and
the recovery of demand.
As part of the travel process, COVID19 testing
would need to be conducted by trained public health officials and
meet the following criteria:
Speed: Testing results should be delivered
quickly, with results available in under an hour as the minimum
standard.
Scale: If testing takes place at the
airport, testing capacity of several hundreds of tests per hour
must be achievable. The use of saliva for taking samples rather
than nasal or throat swabs would facilitate this and would also be
expected to reduce time and improve passenger acceptance.
Accuracy: Extremely high accuracy is
essential. Both false negative and false positive results must be
below 1%.
Where does testing fit in the travel process?
Ideally COVID19 testing would be required in
advance of arrival at the airport and within 24 hours of travel.
Passengers arriving “ready-to-fly” reduces the risk of contagion
in the airport and enables early re-accommodation for any traveler
who tests positive.
If testing is required as part of the travel
process, it is recommended at departure. Governments would need to
mutually recognize test results and data transmission should take
place directly between passengers and governments in a similar
manner as e-visa clearances are currently handled.
Any testing requirements should only be in place
for as long as necessary. To ensure this, regular evaluations
should be conducted.
Who Should Pay?
Cost is an important consideration. Testing should
facilitate travel and not provide an economic barrier. With
testing at some European destinations costing in excess of $200,
this is a real concern.
IATA supports the World Health
Organization (WHO) International Health Regulations which requires
governments to bear the costs of mandatory health testing. Where a
test is offered on a voluntary basis, it should be charged at cost
price.
What happens when someone tests positive?
If testing takes place prior to travel or at
the point of departure and a positive result would mean that the
passenger could not travel as planned. In this case, airlines have
been offering flexibility to consumers. This includes re-booking
or refunds in line with the airline’s commercial policy. Many
airlines are offering the same flexibility to passengers who
suspect that they have symptoms consistent with COVID19 as well as
members of the same traveling party, particularly when they are
members of the same household.
If testing is mandated on arrival and a passenger
tests positive, then the passenger should be treated according to
the requirements of the receiving State. Airlines should not be
required to repatriate the passenger(s) or ‘punished’ with
financial penalties such as fines or through operational penalties
such as the withdrawal of the right to operate in the market.
See latest
Travel News,
Video
Interviews,
Podcasts
and other
news regarding:
COVID19,
IATA.
Headlines: |
|
|